News|Articles|January 11, 2026

Weekly review: New dietary guidelines, ACIP endorsement, and much more

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, January 4, to Friday, January 9, 2026), and click on each link to read and watch anything you may have missed.

New Dietary Guidelines emphasize whole foods and child nutrition

The US Department of Health and Human Services (HHS) and the US Department of Agriculture (USDA) have released the Dietary Guidelines for Americans, 2025–2030, outlining a shift in federal nutrition policy toward whole, minimally processed foods and age-specific dietary recommendations. The updated guidance, released by HHS Secretary Robert F. Kennedy, Jr., and USDA Secretary Brooke Rollins, places renewed emphasis on food-based approaches to health and includes expanded recommendations for infants, children, adolescents, and other population groups.

Click here for the full article.

ACIP endorses GSK pentavalent meningococcal vaccine for concurrent MenACWY and MenB use

The Advisory Committee on Immunization Practices (ACIP) has issued updated guidance supporting the use of a second pentavalent meningococcal vaccine, MenACWY-CRM/MenB-4C (Penmenvy; GSK), when both quadrivalent meningococcal conjugate (MenACWY) and serogroup B meningococcal (MenB) vaccines are indicated at the same clinical encounter for persons 10 years or older.

Click here for the full article.

How prenatal COVID-19 vaccination can reduce severe disease risk, with Elisabeth McClymont, PhD

Elisabeth McClymont, PhD, assistant professor at the University of British Columbia, discussed findings from a study evaluating the impact of COVID-19 vaccination during pregnancy on severe maternal disease and preterm birth. The results demonstrate clear and clinically meaningful benefits of vaccination for both pregnant individuals and their infants.

Click here to watch this video interview.

GLP-1 receptor agonist use linked to fewer asthma exacerbations in adolescents with overweight or obesity

An association between use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and a lower risk of acute asthma exacerbations among adolescents with overweight or obesity was observed in a recent research letter published in JAMA Network Open.

Click here for the full study details.

PreTRM Test and targeted interventions lower preterm birth risks in PRIME trial

Results from a large randomized controlled trial found that use of a mid–second-trimester maternal blood biomarker test, combined with targeted preventive interventions for those identified as higher risk, significantly improved neonatal outcomes in pregnancies otherwise considered low risk for spontaneous preterm birth.

Click here for the full study details.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.